Jace Yawnick was diagnosed with primary mediastinal B-cell non-Hodgkin lymphoma in Jan. 2024 at 25 years old. However, ...
Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...
Yescarta (axicabtagene ciloleucel) has been approved as a treatment for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma ...
The mediastinal mass was noninvasive, suggestive of a primary thymic tumor 4,6 and not a thymic lymphoma. Histologically, the positive staining of the atypical epithelioid cells with the ...